Literature DB >> 10688756

Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.

J Jinno1, D m Oh, J R Crison, G L Amidon.   

Abstract

This study reports the results of the combined effect of pH and surfactant on the dissolution of piroxicam (PX), an ionizable water-insoluble drug in physiological pH. The intrinsic dissolution rate (J(total)) of PX was measured in the pH range from 4.0 to 7.8 with 0%, 0.5%, and 2.0% sodium lauryl sulfate (SLS) using the rotating disk apparatus. Solubility (c(total)) was also measured in the same pH and SLS concentration ranges. A simple additive model including an ionization (PX <--> H(+) + PX(-)) and two micellar solubilization equilibria (PX + micelle <--> [PX](micelle), PX(-) + micelle <--> [PX(-)](micelle)) were considered in the convective diffusion reaction model. J(total) and c(total) of PX increased with increasing pH and SLS concentration in an approximately additive manner. Nonlinear regression analysis showed that observed experimental data were well described with the proposed model (r(2) = 0.86, P < 0.001 for J(total) and r(2) = 0.98, P < 0.001 for c(total)). The pK(a) value of 5.63 +/- 0.02 estimated from c(total) agreed well with the reported value. The micellar solubilization equilibrium coefficient for the unionized drug was estimated to be 348 +/- 77 L/mol, while the value for the ionized drug was nearly equal to zero. The diffusion coefficients of the species PX, PX(-), and [PX](micelle) were estimated from the experimental results as (0. 93 +/- 0.35) x 10(-5), (1.4 +/- 0.30) x 10(-5), and (0.59 +/- 0.21) x 10(-5) cm(2)/s, respectively. The total flux enhancement is less than the total solubility enhancement due to the smaller diffusion coefficients of the micellar species. This model may be useful in predicting the dissolution of an ionizable water insoluble drug as a function of pH and surfactant and for establishing in vitro-in vivo correlations, IVIVC, for maintaining bioequivalence of drug products. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2000        PMID: 10688756     DOI: 10.1002/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional wood's apparatus.

Authors:  Alex Avdeef; Oksana Tsinman
Journal:  Pharm Res       Date:  2008-07-22       Impact factor: 4.200

2.  Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.

Authors:  Ekarat Jantratid; Niels Janssen; Christos Reppas; Jennifer B Dressman
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

3.  Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs.

Authors:  Konstantin Tsinman; Alex Avdeef; Oksana Tsinman; Dmytro Voloboy
Journal:  Pharm Res       Date:  2009-06-19       Impact factor: 4.200

4.  Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug.

Authors:  Arthur Okumu; Marie DiMaso; Raimar Löbenberg
Journal:  Pharm Res       Date:  2008-06-17       Impact factor: 4.200

5.  Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media.

Authors:  Anita Maria Persson; Curt Pettersson; Josefin Rosén
Journal:  Pharm Res       Date:  2010-03-27       Impact factor: 4.200

6.  Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.

Authors:  Nadia Bou-Chacra; Katherine Jasmine Curo Melo; Ivan Andrés Cordova Morales; Erika S Stippler; Filippos Kesisoglou; Mehran Yazdanian; Raimar Löbenberg
Journal:  AAPS J       Date:  2017-05-17       Impact factor: 4.009

7.  Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines.

Authors:  Hyun-Ah Cheong; Hoo-Kyun Choi
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

8.  Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation.

Authors:  Viral F Patel; Natavarlal M Patel
Journal:  AAPS PharmSciTech       Date:  2006-02-24       Impact factor: 3.246

9.  Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.

Authors:  Jennifer J Sheng; Daniel P McNamara; Gordon L Amidon
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

10.  Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.

Authors:  Muthanna F Abdulkarim; Ghassan Z Abdullah; Mallikarjun Chitneni; Ibrahim M Salman; Omar Z Ameer; Mun F Yam; Elrashid S Mahdi; Munavvar A Sattar; Mahiran Basri; Azmin M Noor
Journal:  Int J Nanomedicine       Date:  2010-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.